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Synaptogenesis, the formation of functional synapses, is a crucial step for the development of the 
central nervous system. Among the genes involved in this process, cell adhesion molecules, such 
as protocadherins and neuroligins, are essential factors for the identification of the appropriate 
partner cell and the formation of synapses. In this work, we studied the expression and the 
genetic variability of two closely related members of the protocadherin family PCDH11X/Y, 
located on the X and the Y chromosome, respectively. PCDH11Y is one of the rare genes specific 
to the hominoid lineage, absent in other primates. Expression analysis indicated that transcripts 
of the PCDH11X/Y genes are mainly detected in the cortex of the human brain. Mutation 
screening of thirty individuals with autism identified two PCDH11Y polymorphic amino acid 
changes, F885V and K980N. These variations are in complete association, appeared during 
human evolution approximately 40000 years ago and represent informative polymorphisms to 
study Y chromosome variability in populations. We studied the frequency of these variants in 
males with autism spectrum disorders (n = 110), attention deficit hyper-activity disorder 
(ADHD; n = 61), bipolar disorder (n = 61), obsessive-compulsive disorder (n = 51) or 
schizophrenia (n = 61) and observed no significant differences when compared to 
geographically-matched control populations. These findings do not support the role of 
PCDH11Y, or more generally of a frequent specific Y chromosome, in the susceptibility to these 
neuropsychiatric disorders. 
 
KEYWORDS: Autism, schizophrenia, obsessive-compulsive disorder, bipolar disorder, 
synaptogenesis 
 
INTRODUCTION 
The role of neuronal cell adhesion molecules—including neuroligins (NLGN) and protocadherins 
(PCDH)—in psychiatric disorders was recently evidenced by the identification of mutations in 
NLGN3 and NLGN4 in autism and Asperger syndrome [Jamain et al., 2003]. In addition, a rare variant 
of the protocadherin PCDH8 was observed in a family with two sibs with schizophrenia [Bray et al., 
2002]. PCDH are neuronal cell-surface proteins that bind in a homophilic manner to each other and 
form symmetric intercellular junctions.  
PCDH genes have a complex genomic organization with multiple variable exons and a set of 
constant exons, similar to the immunoglobulin (Ig) and T-cell receptor (TCR) genes. Furthermore, 
PCDH genes can be monoallelically expressed from a single neuron [Esumi et al., 2005]. Therefore, 
this huge diversity of PCDH expression can be used to specify individual neuronal cell identity and 
could play a crucial role in establishing the blueprint of the neuronal networks in humans [Hilschmann 
et al., 2001]. PCDH11Y is one of the rare genes specific of the hominoid lineage and absent from 
other primates [Blanco et al., 2000]. It is located on the Y chromosome and originates from a 
translocation of the PCDH11X gene after the divergence between chimpanzees and humans [Blanco et 
al., 2000; Blanco-Arias et al., 2004]. The X inactivation profile of PCDH11X as well as the function 
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and the neuronal specificity of the proteins PCDH11X and PCDH11Y remain unknown. However, the 
role of the PCDH during development and the recent origin of PCDH11Y make these genes strong 
candidates for susceptibility to psychiatric disorders [Giouzeli et al., 2004]. In particular, PCDH11Y 
could be a susceptibility gene for autism and attention deficit hyperactivity disorder (ADHD), in 
which males are more affected than females and for schizophrenia and obsessive compulsive disorder 
(OCD), in which the age of onset is younger in males. 
In this paper, we report the expression pattern of both genes in the human brain and their sequence 
variability in patients with autism spectrum disorders, ADHD, bipolar disorder, OCD, and 
schizophrenia. 
 
PATIENTS AND METHODS 
French (n = 72) and Swedish (n = 38) male probands, fulfilling the DSM-IV and ICD-10 criteria for 
autistic disorder, Asperger syndrome or pervasive developmental disorder not otherwise specified 
were recruited by the Paris Autism Research International Sib-pair (PARIS) study. One hundred 
individuals (91%) met the Autism Diagnostic Interview-Revised (ADI-R) criteria for autism [Lord et 
al., 1994]. Subjects were included after a clinical and medical work-up comprising neuropsychological 
examination, standard karyotyping, fragile-X testing, and blood and urine analyses for metabolic 
screening; brain imaging and EEG were performed when possible. Patients with associated medical 
disorders were excluded from the study.  
Swedish male patients fulfilling diagnostic criteria according to the DSM-IV for ADHD (n= 61) 
were recruited at the Child Neuropsychiatric Clinic in Göteborg after a comprehensive psychiatric and 
medical assessment to assign diagnosis based on standard instruments such as the Conner's scale and 
to exclude associated somatic conditions.  
French male patients with schizophrenia (n = 61) or bipolar disorder (n= 61) were recruited at the 
Albert Chenevier Hospital, Créteil, France. French male probands with OCD (n = 51) were recruited 
at the Robert Debré Hospital, Paris, France. All cases met DSM-IV criteria for one of these disorders 
[American Psychiatric Association, 1994]. Lifetime psychiatric evaluation was carried out during a 
direct interview by trained psychiatrists using the Diagnostic Interview for Genetic Studies (DIGS) 
[Nurnberger et al., 1994].  
French (n= 86) and Swedish (n = 47) healthy male controls were recruited among blood donors at 
the Pitié-Salpétrière Hospital in Paris, France and at the University of Göteborg in Göteborg, Sweden. 
The sample of French controls from European descent was included after being interviewed with the 
DIGS to confirm the absence of both personal and family history of psychiatric disorders in first- and 
second-degree relatives.  
All patients and controls were of European descent. The local Research Ethics Boards reviewed 
and approved the study. Written informed consent was obtained from all controls, probands, and their 
parents. If the proband was under 18 years old, the proband's consent and written parental consent 
were obtained.  
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DNA and Statistical Analysis 
DNA extracted from blood leukocytes or lymphoblastoid cell lines was used to amplify the 
PCDH11X/Y genes; sequence analysis was performed by direct sequencing of the PCR products, using 
a 373A automated DNA sequencer (Applied Biosystems, Foster City, CA). For expression studies, 1 
µg of total RNA from different regions of the human brain was isolated by the acid-guanidium 
thiocyanate phenol chloroform method [Chomczynski and Sacchi, 1987] and reverse transcribed using 
the Gene Amp RNA PCR kit (Perkin-Elmer Corp., Norwalk, CT). Transcripts containing exons E4 
and E5 were amplified with primers E4F (CCGGATGAAATATTTAGACTGGTT) and E5R1 
(TATGGTCCGCATCCTTATCC). Transcripts containing exons E3, E4 and E5 were amplified with 
primers E3F (GTGGGTTTTAATTCAGATATT) and E5R2 (TGTTTCTTCCCTATCCAGTGG). 
Transcripts containing exons E4.1 and E5 were amplified with primers E4bF 
(CATGCATGTTTAGGGTTGGCT) and E5R2. For genotyping of the FK and VN PCDH11Y 
haplotypes, a fragment of exon 5 was amplified using primers E5F 
(CACAAGAGATCTGTTTGCAATCGA) and E5R3 (AGAAAGTTGTGTTAGAAACTTGG). After 
amplification, 15 µl of PCR products were digested with 1µl Tsp509 I (New England BioLabs, 
Ipswich, MA). The products were loaded on a 3% 1:1 agarose:nusieve gel. Differences in haplotype 
frequencies were evaluated using a homogeneity χ2 test. 
 
RESULTS 
Expression of the PCDH11X/Y in the Human Brain 
In order to study the pattern of expression of the PCDH11X/Y genes in the human brain, RT-PCRs of 
transcripts from both genes were performed on RNA isolated from different brain regions using 
primers with identical sequences for PCDH11X and PCDH11Y (Fig. 1). These RT-PCR results are 
nonquantitative and should be taken with care. Discrimination between the product amplify from 
PCDH11X and PCDH11Y mRNA was done by restriction analysis, taking advantage of a BsaAI site 
present only in the PCDH11X sequence. In males, PCDH11Y transcripts seem to be more abundant 
than PCDH11X. This difference could be due to the presence of an additional promoter upstream of 
exon 4 of PCDH11Y. The similar region appears to be non-functional on the X chromosome (Fig. 1). 
Expression of the PCDH11X and PCDH11Y genes (originating from two promoters in the case of 
PCDH11Y) is mainly restricted to the cortex (frontal, temporal, and occipital) and the hippocampus, is 
less abundant in the thalamus and is virtually absent from the cerebellum. 
 
Variation of PCDH11X/Y in Individuals With Psychiatric Disorders 
Exons 3-5 of the PCDH11X and PCDH11Y genes were directly sequenced in a subset of 30 males 
with autism. No non-synonymous variation was identified in the PCDH11X gene. In contrast, two 
variations, F885V and K980N, were identified in exon 5 of the PCDH11Y gene. As recently reported, 
these variations were always found in association, thus defining only two haplotypes (FK and VN) 
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[Giouzeli et al., 2004; Lopes et al., 2004]. Both amino acids are conserved during evolution and are 
located in the intracellular part of the protein (Fig. 2a).  
The FK haplotype is probably the ancestral one since the amino acids F885 and K980 are present 
in PCDH11X from human, chimpanzee and mouse, as well as in other protocadherins (Fig. 2a). We 
previously reported the Y chromosome haplotypes of 111 males with autism from France, Sweden and 
Norway [Jamain et al., 2002]. Using this information, we could ascertain the origin of the novel VN 
haplotype of PCDH11Y in the P lineage of the human Y chromosome phylogeny [Y Chromosome 
Consortium, 2002]. Specifically, the VN haplotype is present in Y chromosomes carrying variation P-
92R7-T (lineage P, variation 92R7, allele T), whereas the FK haplotype occurs in Y chromosomes 
carrying the variation P-92R7-C (not shown). The P lineage originated approximately 40,000 years 
ago and is the ancestor of P-M173 (lineage P, variation M173), the major Y chromosome haplotype in 
Europe [Wells et al., 2001]. 
Frequencies of both the FK and VN haplotypes of PCDH11Y were determined in male patients 
with psychiatric diseases (Fig. 2b). None of the affected populations showed significant differences in 
their haplotype frequency (Fig 2c) compared to ethnically-matched controls. A significant difference 
was found when French and Swedish controls were compared (p= 0.0046). This genetic difference 
underlies the diverse migration of Homo sapiens during the settlement of Europe 40,000 years ago 
[Wells et al., 2001]. 
 
DISCUSSION 
PCDH11X/Y are potential functional candidates that might bear on susceptibility to psychiatric 
diseases for three main reasons. First, they are members of the PCDH family, which is known to play 
a major role in synapse recognition and neuronal path finding during brain development [Hilschmann 
et al., 2001]. Second, PCDH11Y is one of the rare genes located on the Y chromosome with a strong 
regulated expression in the brain [Blanco et al., 2000; Blanco-Arias et al., 2004]. Third, PCDH11Y is 
specific to humans and may have acquired a new function in the wiring of the human brain. As 
suggested by Crow [Crow, 1999], this new connectivity may play a role in human specific cognitive 
functions, such as language, and consequently in conferring susceptibility to psychiatric disorders such 
as autism spectrum disorders and schizophrenia. 
The RT-PCR analysis of PCDH11X and PCDH11Y transcripts revealed a strong expression in the 
cortex and hippocampus and less in the cerebellum. This pattern suggests that both proteins are 
involved in the recognition or path finding of neurons originating in the cortex and the hippocampus. 
During evolution, several Y chromosomal genes having a homologue on the X chromosome were 
rapidly converted into non-functional pseudogenes. Nevertheless, the presence of a specific PCDH11Y 
promoter with a regulated expression pattern, and the absence of a stop codon in the coding sequence 
strongly suggest that PCDH11Y is not a pseudogene.  
The two PCDHY non-synonymous variations, F885V and K980N, concern conserved amino 
acids and may modify the properties of the protein, such as the ability of PCDH11Y to perform signal 
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transduction. Interestingly, these two amino acid changes probably appeared on the Y chromosome at 
the same time or during a short time window, since we did not observe any FN or VK haplotypes in 
the individuals tested (n = 477). Comparison between the two control populations indicated that the 
VN haplotype is more frequent in France, whereas in Sweden, the FK haplotype is more common. 
Nevertheless, a comparison between probands and ethnically-matched controls did not show any 
significant difference in haplotype frequencies. These results suggest that any contribution of 
PCDH11Y to psychiatric diseases is likely to be weak, although the existence of rare variations of 
stronger effect cannot be excluded. Furthermore, using these Y-linked informative polymorphisms, we 
could document Y chromosome variability in autism, ADHD, OCD, bipolar disorder and 
schizophrenia. Given that most of the Y chromosome does not recombine, a unique sequence 
variation on this chromosome can be representative of a whole group of Y chromosomes (called 
haplogroups) [Y Chromosome Consortium, 2002]. This non-recombining property of the Y 
chromosome has been intensively used to understand the origin and the migration of human 
populations. Therefore, the absence of significant differences in haplotype frequencies between 
affected individuals and controls also supports the absence of a specific Y chromosome effect on 
the susceptibility to the neuropsychiatric disorders studied.  
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Fig. 1. Expression analysis of PCDH11X/Y in the human brain. Specific RT-PCRs were performed on 
total RNA from different brain regions using primers with identical sequences for both PCDH11X and 
PCDH11Y. Discrimination between PCDH11X and PCDH11Y mRNA was done by restriction 
analysis taking advantage of a BsaAI site present only in the PCDH11X sequence. Primers in exons 4 
and 5 (top panel) amplified the E4E5 transcript, which contains the two exons (E4 and E5) retained in 
all isoforms of both PCDH11X and PCDH11Y. Primers in exons 3 and 5 (middle panel) amplified the 
isoforms retaining exon 3 and originating from the promoter upstream of exon 1. Primers in exons 4.1 
and 5 (bottom panel) amplified the isoforms originating from the promoter upstream of exon 4.1 and 
specific to the PCDH11Y gene. Normal control human brains were obtained at autopsy under 
guidelines approved by the Ethics Committee. The ages of the two males and the two females studied 
were 74, 42, 55, and 36 year-old, with a post-mortem delay of 10, 21, 24, and 2 hr, respectively. f: 
frontal cortex, tc: temporal cortex, o: occipital cortex, h: hippocampus, t: thalamus; c: cerebellum. 
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Fig. 2. Conservation, genotyping and frequencies of the two PCDH11Y haplotypes in control and 
affected populations. a: Protein structure and sequence alignment of protocadherins from different 
species. PCDH9 is the closest homologue of PCDH11 in the protocadherin phylogeny. SPV, signal 
peptide variations; Tm, transmemebrane domain; CD, cadherin domain; CyDV, cytoplasmic domain 
variations. b: Genotyping of the two PCDH11Y haplotypes FK and VN by restriction analysis using 
the enzyme Tsp509 I. c: Frequencies of the PCDH11Y haplotypes FK and VN in the French and 
Swedish male samples. The French sample sizes are the following: autism spectrum disorder (AU, n 
=72), obsessive-compulsive disorder (OCD, n = 51), bipolar disorder (BP, n = 61), schizophrenia 
(SCZ, n = 61) and controls (C, n = 86). The Swedish sample sizes are 61, 38 and 47 for ADHD, 
autism spectrum disorder (AU) and controls (C), respectively. 
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